Noah Dean Miller Dmd Llc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 2729 Rainbow Dr, Rainbow City, AL 35906 Phone: 256-442-8081 Fax: 256-442-8082 |
Isbell Dental Blue Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3228 Rainbow Dr, Rainbow City, AL 35906 Phone: 256-442-1797 |
Smith And Bailey Dental Dentist Medicare: Not Enrolled in Medicare Practice Location: 3343 Rainbow Dr, Rainbow City, AL 35906 Phone: 205-456-5936 |
Rainbow City Family Dentistry, Llc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 2729 Rainbow Dr, Rainbow City, AL 35906 Phone: 256-442-8081 |
News Archive
A large international study aimed at improving the care of muscular dystrophy patients worldwide is being launched by physicians, physical therapists, and researchers at the University of Rochester Medical Center.
The obesity rate may rise to 42 percent from about a third of the U.S. population by 2030 if nothing changes, according to a report. Preventing that increase may save about $550 billion in medical costs over the next 20 years, Eric Finkelstein, the study author and an associate research professor at Duke University, said during a press briefing.
Researchers at Karolinska Institutet have received an additional 1.4 million Euro from business magnate Fredrik Lundberg for research into bicuspid aortic valve and its links to aneurysm.
Individuals who take aspirin or other medications that prevent blood clotting by inhibiting the accumulation of platelets appear more likely to have tiny, asymptomatic areas of bleeding in the brain, according to a report posted online today that will appear in the June print issue of Archives of Neurology.
EpiCept Corporation today announced that the Israeli Ministry of Health has approved the marketing application for CepleneĀ®, indicated for remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia (AML) in first remission. Megapharm Ltd. is EpiCept's partner in Israel and upon Ministry of Health approval of labeling and other technical matters the company is expected to launch CepleneĀ® in the first quarter of 2011.
› Verified 3 days ago